TICAGRELOR
NDC 73190-003, TICAGRELOR, tablet, from AvKARE.
- Product NDC
- 73190-003
- Status
- Listed
- Labeler
- AvKARE
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208596
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73190-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TICAGRELOR60 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; P-Glycoprotein Inhibitors [MoA]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73190-003-60 | 73190000360 | 60 TABLET in 1 BOTTLE (73190-003-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/40bb0fb0-2275-4df7-e063-6394a90ade2e
Use it
Look up 73190-003 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73190-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73190-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.